Basit öğe kaydını göster

dc.contributor.authorNasonov, EL
dc.contributor.authorHazenberg, BPC
dc.contributor.authorBijzet, J
dc.contributor.authorButrimiene, I
dc.contributor.authorLivneh, A
dc.contributor.authorLesnyak, O
dc.contributor.authorHawkins, PN
dc.contributor.authorFilipowicz-Sosnowska, A
dc.contributor.authorMerlini, G
dc.contributor.authorObici, L
dc.contributor.authorGui, A
dc.contributor.authorWiland, R
dc.contributor.authorOzdogan, H
dc.contributor.authorGorevic, PD
dc.contributor.authorDember, LM
dc.contributor.authorSkinner, M
dc.contributor.authorBen Maiz, H
dc.contributor.authorBriand, R
dc.contributor.authorGarceau, D
dc.contributor.authorHauck, W
dc.date.accessioned2021-03-06T21:10:21Z
dc.date.available2021-03-06T21:10:21Z
dc.identifier.citationHazenberg B., Bijzet J., Butrimiene I., Livneh A., Lesnyak O., Nasonov E., Hawkins P., Filipowicz-Sosnowska A., Merlini G., Obici L., et al., "Impact of fibrillex, an anti-amyloid product, on amyloid A (AA) protein content in abdominal fat tissue biopsies from patients with AA amyloidosis: Results from a pivotal international trial", Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.223
dc.identifier.othervv_1032021
dc.identifier.otherav_fd878351-276b-464f-9662-754820309ae8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/165851
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİmmünoloji ve Romatoloji
dc.titleImpact of fibrillex, an anti-amyloid product, on amyloid A (AA) protein content in abdominal fat tissue biopsies from patients with AA amyloidosis: Results from a pivotal international trial
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume64
dc.contributor.firstauthorID131081


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster